dexchlorpheniramine has been researched along with paclitaxel in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bonneterre, J; Dauplat, J; Fumoleau, P; Guastalla, JP; Kerbrat, P; Lhommé, C; Namer, M; Oberling, F; Pouillart, P; Tubiana, N | 1 |
| Chargari, C; Libert, N; Magne, N; Meillan, N; Tanz, R; Vedrine, L | 1 |
1 review(s) available for dexchlorpheniramine and paclitaxel
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for dexchlorpheniramine and paclitaxel
| Article | Year |
|---|---|
Taxol (paclitaxel) safety in patients with platinum pretreated ovarian carcinoma: an interim analysis of a phase II multicenter study.
Topics: Adult; Aged; Chlorpheniramine; Cimetidine; Female; Humans; Infusions, Intravenous; Middle Aged; Ovarian Neoplasms; Paclitaxel; Platinum; Prednisolone; Premedication; Prospective Studies; Salvage Therapy; Stereoisomerism | 1994 |
1 other study(ies) available for dexchlorpheniramine and paclitaxel
| Article | Year |
|---|---|
Successful readministration of trastuzumab after severe immune reactions in two breast cancer patients.
Topics: Adult; Anaphylaxis; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bronchodilator Agents; Chlorpheniramine; Female; Histamine H1 Antagonists; Humans; Ipratropium; Methylprednisolone; Middle Aged; Paclitaxel; Receptor, ErbB-2; Trastuzumab | 2014 |